Pharma SmartPhone/Tablet Apps: Is There a Regulation for That?
Pharmaceutical marketers have jumped on the mobile application bandwagon as more and more companies roll out health-related applications for smartphones and touchpads such as Apple's iPhone and iPad. But will the FDA regulate certain smartphone apps as medical devices? This article discusses the regulatory and other issues associated with pharma developed or sponsored health apps.
Mining Mobile Health App User Data: Liberating Health Data While Protecting Privacy
A conversation with Jacqueline Thong, co-founder and CEO of Ubiqi Health, about disease management mobile applications and how pharma marketers can leverage mobile health apps to engage with and learn from patients.
Pharma Marketing News Vol. 10, No. 12: 20 July 2011
Welcome to Volume 10, Issue #12 (20 JULY 2011) of Pharma Marketing News.
Citizen Petition Likely to Delay FDA Social Media Guidance
Allergan, Eli Lilly, Johnson and Johnson, Novartis, Pfizer, Novo, and Sanofi-Aventis filed a 'citizen petition' with the FDA, urging the agency to 'establish comprehensive, clear and binding regulations to guide the industry' in communicating off-label drug information to physicians and payers. Although the words 'Internet' and 'Social Media' are not mentioned in the petition, it is likely to hold up social media guidelines regarding 'unsolicited requests' that were promised as the first in a series of FDA guidelines.
Events I Witnessed, News You Made, & People We Met
The year 2010 was all about me. By 'me' I mean Pharmaguy, which is the Twitter handle and Facebook name of John Mack, Editor and Publisher of Pharma Marketing News. It's all about YOU too! This is where you can 'sign' the 2010 Pharma Marketing Yearbook and and document that you were part of it all.
Vast Majority of Drug Ads in Leading Medical Journals Don’t Pass MDs’ Sniff Test!
A study led by Mount Sinai School of Medicine researchers of 192 pharmaceutical advertisements (83 full unique advertisements) in biomedical journals found that only 18 percent (15) were compliant with Food and Drug Administration (FDA) guidelines, and over half failed to quantify serious risks including death.
Pharma Marketing News Vol. 10, No. 7: 15 April 2011
Welcome to Volume 10, Issue #7 (15 APRIL 2011) of Pharma Marketing News.
Implications of Facebook’s Page Commenting Changes
A discussion with Jonathan Richman, Group Director, Insights and Planning at Possible Worldwide about Facebook's changes to its commenting policies and his recommendations for pharma marketers who wish to develop Facebook pages.
The Pozen Digital Advisory Board
A conversation with Elizabeth A. Cermak, EVP, and Chief Commercial Officerat Pozen, Raj Amin, CEO and Co-Founder of HealthiNation, and Bonin Bough, Senior Global Director of Digital and Social Media, PepsiCo, about the who, what, why behind the Pozen Digital Advisory Board, an esteemed group of digital thought-leaders both in and outside of healthcare.
Boehringer vs Facebook Social Media Socialism
Boehringer-Ingelheim (BI) stands out in its attempt to stand out from the social(ist) cookie-cutter crowd of pharma FB pages. Shows what you can do with dedicated resources and creativity.
